Dialectical Behavior Therapy for Borderline Personality Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines the effectiveness of a therapy called DBT-A (Dialectical Behavior Therapy for Adolescents) for young people showing signs of borderline personality disorder (BPD). The goal is to assist adolescents aged 13-20 who experience issues like impulsive behavior or frequent self-harm. Participants must exhibit at least three symptoms of BPD, including impulsivity or self-harm, and live close enough to the clinic to attend weekly sessions. The study includes individual therapy, family skills groups, and other supportive activities, aiming to enhance emotional regulation and overall well-being. As an unphased trial, this study provides a unique opportunity for participants to contribute to the understanding and improvement of mental health therapies for adolescents.
Will I have to stop taking my current medications?
The trial does not require you to stop taking your current medications. You only need to stop other forms of talk therapy during the program, but you can continue with medication management.
What prior data suggests that DBT-A is safe for adolescents with borderline personality disorder?
Research has shown that Dialectical Behavior Therapy for Adolescents (DBT-A) is generally safe and well-tolerated. In a small study, 12 teenagers showed significant improvements in their symptoms after receiving DBT-A treatment. Studies also report a clear reduction in self-harm behavior among participants following the therapy.
Additionally, research indicates that DBT, the therapy from which DBT-A is adapted, effectively and safely treats borderline personality disorder and related issues. These findings suggest that DBT-A can be safely used with teenagers facing emotional challenges and symptoms of borderline personality disorder.12345Why are researchers excited about this trial?
Dialectical Behavior Therapy for Adolescents (DBT-A) is unique because it specifically tailors the standard DBT model for adolescents struggling with Borderline Personality Disorder (BPD) features. Unlike typical treatments that may focus solely on individual therapy, DBT-A combines weekly individual sessions, multifamily skills groups, and phone coaching to involve the family in the therapeutic process. Researchers are excited about DBT-A because this comprehensive approach addresses emotional dysregulation in adolescents more holistically, potentially leading to better outcomes by engaging both the young person and their family in the healing process.
What evidence suggests that DBT-A might be an effective treatment for borderline personality disorder?
Research has shown that Dialectical Behavior Therapy for Adolescents (DBT-A), the treatment model delivered to all participants in this trial, effectively treats symptoms of borderline personality disorder (BPD) in young people. One study found that DBT-A greatly reduced BPD symptoms and improved emotional management, common issues for those with the disorder. Another study showed that DBT-A decreased self-harm and enhanced overall emotional health. Evidence also suggests that attending group-based DBT skills training can lead to positive changes. Overall, DBT-A effectively addresses key symptoms of BPD in adolescents.16789
Are You a Good Fit for This Trial?
This trial is for adolescents aged 13-20 with borderline personality disorder, showing impulsive behavior or self-harm. They must live close to the clinic and have a caregiver join in treatment. Participants can't be in other talk therapies, must understand English, have an IQ above 70, and not require services for conditions like schizophrenia.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Dialectical Behavior Therapy for Adolescents (DBT-A) over a six-month period, including weekly individual therapy, weekly multifamily skills group, phone coaching as needed, and therapist consultation
Mid-treatment Assessment
Participants are assessed at the three-month mark to evaluate progress and adjust treatment as necessary
Post-treatment Assessment
Participants are assessed at the end of the six-month treatment period to evaluate outcomes
Follow-up
Participants are monitored for safety and effectiveness three months after treatment completion
What Are the Treatments Tested in This Trial?
Interventions
- DBT-A
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor